Misclassification of UDCA treatment response in patients with primary biliary cholangitis (PBC) in the real-world setting

Annals of Hepatology · Published 2026-06-01 · DOI 10.1016/j.aohep.2026.102254

Free full text

Authors (6)

Annegret Franke, Tobias Müller, Kerstin Stein, Heike Bantel, Rainer Günther, Johannes Wiegand

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Franke, A., Müller, T., Stein, K., et al. (2026). Misclassification of UDCA treatment response in patients with primary biliary cholangitis (PBC) in the real-world setting. Annals of Hepatology. https://doi.org/10.1016/j.aohep.2026.102254

Related articles

• Metabolic dysfunction–associated steatotic liver disease: No alcohol · Annals of Hepatology · 2026 · Same journal
• The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease · Annals of Hepatology · 2026 · Same journal
• The global academic hepatology capacity index (IGCAH): a multi-source assessment reveals profound inequities across Latin America · Annals of Hepatology · 2026 · Same journal
• The AMAGE guidelines: Metabolic dysfunction-associated fatty liver disease through a regional lens · Annals of Hepatology · 2026 · Same journal
• Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease · Annals of Hepatology · 2026 · Same journal
• Similar hepatic outcome by SGLT2i vs. DPP4i for at-risk cohort with CHB & T2DM: A nationwide target trial emulation study · Annals of Hepatology · 2025 · Same journal
• Pragmatism should not eclipse validation in expanded HBV management for Latin America: response · Annals of Hepatology · 2026 · Same journal
• Mesencephalic astrocyte-derived neurotrophic factor (MANF): a context-dependent therapeutic regulator and potential biomarker in liver diseases · Annals of Hepatology · 2026 · Same journal
• The role of inpatient palliative care consultation in end-stage liver disease: Too little, too late? · Annals of Hepatology · 2026 · Same journal
• Sarcopenia risk in liver transplant candidates: Should artificial intelligence-based body composition analysis be incorporated into pre-transplant assessment? · Annals of Hepatology · 2026 · Same journal